Company profile for Shasqi

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our technology, based on bioorthogonal chemistry, enables the activation of small molecule drugs at the local tissue-level, improving both their efficacy and safety. The method is independent of endogenous cellular or environmental markers and allows the activation of drugs at a specific location for multiple weeks after the initial injection of the biomaterial at the desired site. Shasqi has created a new way to deliver drugs...
Our technology, based on bioorthogonal chemistry, enables the activation of small molecule drugs at the local tissue-level, improving both their efficacy and safety. The method is independent of endogenous cellular or environmental markers and allows the activation of drugs at a specific location for multiple weeks after the initial injection of the biomaterial at the desired site. Shasqi has created a new way to deliver drugs in the body. Our proprietary local drug activation technology allows delivery of more drug to the tumor with fewer side effects.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
San Francisco, California
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/shasqi-strengthens-board-of-directors-with-the-appointment-of-former-chief-development-officer-at-pfizer-oncology-302572046.html

PR NEWSWIRE
01 Oct 2025

https://www.prnewswire.com/news-releases/shasqi-to-present-data-on-novel-tumor-targeted-drug-activation-technology-at-2024-american-association-for-cancer-research-aacr-annual-meeting-302109112.html

PR NEWSWIRE
05 Apr 2024

https://www.prnewswire.com/news-releases/shasqi-expands-board-of-directors-with-appointment-of-biopharma-executives-302025764.html

PR NEWSWIRE
04 Jan 2024

https://www.prnewswire.com/news-releases/shasqi-to-expand-existing-research-collaboration-to-advance-targeted-cancer-treatment-301946651.html

PR NEWSWIRE
04 Oct 2023

https://www.prnewswire.com/news-releases/shasqi-appoints-oncology-luminaries-to-its-inaugural-scientific-advisory-board-alongside-the-expansion-of-its-leadership-team-301891250.html

PR NEWSWIRE
02 Aug 2023

https://www.businesswire.com/news/home/20230601005498/en

BUSINESSWIRE
01 Jun 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty